CCL1



CCL1

K1KK1S2SS2M3MM3L4LL4T5TT5V6VV6S7SS7N8NN8S9SS9C10CC10C11CC11L12LL12N13NN13T14TT14L15LL15K16KK16K17KK17E18EE18L19LL19P20PP20L21LL21K22KK22F23FF23I24II24Q25QQ25C26CC26Y27YY27R28RR28K29KK29M30MM30G31GG31S32SS32S33SS33C34CC34P35PP35D36DD36P37PP37P38PP38A39AA39V40VV40V41VV41F42FF42R43RR43L44LL44N45NN45K46KK46G47GG47... and 22 more residue(s)...... and 22 more residue(s)

SMILES None
InChIKey None
Sequence KSMLTVSNSCCLNTLKKELPLKFIQCYRKMGSSCPDPPAVVFRLNKGRESCASTNKTWVQNHLKKVNPC

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



No bioactivity data available.

CCL1

K1KK1S2SS2M3MM3L4LL4T5TT5V6VV6S7SS7N8NN8S9SS9C10CC10C11CC11L12LL12N13NN13T14TT14L15LL15K16KK16K17KK17E18EE18L19LL19P20PP20L21LL21K22KK22F23FF23I24II24Q25QQ25C26CC26Y27YY27R28RR28K29KK29M30MM30G31GG31S32SS32S33SS33C34CC34P35PP35D36DD36P37PP37P38PP38A39AA39V40VV40V41VV41F42FF42R43RR43L44LL44N45NN45K46KK46G47GG47... and 22 more residue(s)...... and 22 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.